<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02338830</url>
  </required_header>
  <id_info>
    <org_study_id>WR1</org_study_id>
    <nct_id>NCT02338830</nct_id>
  </id_info>
  <brief_title>Vaginal Progesterone for Prevention of Preterm Labor in Asymptomatic Twin Pregnancies With Sonographic Short Cervix</brief_title>
  <official_title>Vaginal Progesterone for Prevention of Preterm Labor in Asymptomatic Twin Pregnancies With Sonographic Short Cervix</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mohamed Sayed Abdelhafez</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the value of vaginal progesterone therapy for reduction of preterm labor in
      asymptomatic twin pregnancies who have sonographic short cervix
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Women with twin pregnancy with transvaginal sonographic cervical length of 20-25 mm at 20-24
      weeks gestational age without symptoms, signs or other risk factors of preterm labor will be
      included in the study. All women will be randomly divided into two groups; one group (study
      group) received vaginal progesterone suppositories in a dose of 400 mg daily beginning at
      20-24 weeks gestational age (study group) and the other group received no treatment (control
      group)
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Actual">November 2014</completion_date>
  <primary_completion_date type="Actual">October 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Preterm labor before 34 weeks</measure>
    <time_frame>Up to 34 weeks gestational age</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neonatal respiratory distress syndrome (RDS)</measure>
    <time_frame>At birth</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Early neonatal death (END).</measure>
    <time_frame>One month after birth</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">182</enrollment>
  <condition>Premature Labour</condition>
  <arm_group>
    <arm_group_label>Progesterone group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Women received vaginal progesterone suppositories</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No treatment group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Women received no treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Progesterone</intervention_name>
    <description>Women received vaginal progesterone suppositories (CyclogestÂ®, Actavis, Barnstaple, EX32 8NS, United Kingdom) in a dose of 400 mg daily beginning at 20-24 weeks gestational age</description>
    <arm_group_label>Progesterone group</arm_group_label>
    <other_name>Cyclogest</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women pregnant in dichorionic twins.

          -  Transvaginal sonographic cervical length is 20-25 mm at 20-24 weeks gestational age.

          -  No symptoms, signs or other risk factors for preterm labor.

        Exclusion Criteria:

          -  Age &lt; 20 years or &gt; 35 years.

          -  Known allergy or contraindication (relative or absolute) to progesterone therapy.

          -  Pregnancy by in vitro fertilization (IVF) / intracytoplasmic sperm injection (ICSI).

          -  Monochorionic twins.

          -  Known major fetal structural or chromosomal abnormality.

          -  Intrauterine death of one fetus or death of both fetuses.

          -  Fetal reduction in current pregnancy.

          -  Cervical cerclage in current pregnancy.

          -  Medical conditions that may lead to preterm delivery.

          -  Rupture of membranes.

          -  Vaginal bleeding.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Waleed El-refaie, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mansoura University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohamed S Abdelhafez, Dr</last_name>
    <role>Study Director</role>
    <affiliation>Mansoura University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ahmed M Badawy, Prof</last_name>
    <role>Study Chair</role>
    <affiliation>Mansoura University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Obstetrics and Gynecology Department in Mansoura University Hospital</name>
      <address>
        <city>Mansoura</city>
        <state>Dakahlia</state>
        <zip>35111</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Private practice settings</name>
      <address>
        <city>Mansoura</city>
        <state>Dakahlia</state>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>January 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 24, 2014</study_first_submitted>
  <study_first_submitted_qc>January 11, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 14, 2015</study_first_posted>
  <last_update_submitted>January 13, 2015</last_update_submitted>
  <last_update_submitted_qc>January 13, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 15, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Mohamed Sayed Abdelhafez</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>Twins</keyword>
  <keyword>Preterm labor</keyword>
  <keyword>Progesterone</keyword>
  <keyword>Short cervix</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obstetric Labor, Premature</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Progesterone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

